Shinichi Kato Selected Research

Diffuse Idiopathic Skeletal Hyperostosis

8/2022	Factors Affecting Incomplete L5/S Posterior Lumbar Interbody Fusion, Including Spinopelvic Sagittal Parameters.
12/2020	Activities of Daily Living after Surgical Treatment for Osteoporotic Vertebral Fracture with or without Diffuse Idiopathic Skeletal Hyperostosis: A Retrospective Single-Institutional Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinichi Kato Research Topics

Disease

15	Colitis 06/2019 - 01/2004
14	Inflammation (Inflammations) 12/2021 - 09/2004
10	Body Weight (Weight, Body) 07/2021 - 01/2004
6	Stomach Ulcer (Gastric Ulcer) 01/2011 - 05/2002
5	Neoplasms (Cancer) 12/2021 - 05/2012
4	Mucositis 10/2017 - 05/2012
4	Diarrhea 01/2017 - 09/2004
4	Ulcer 01/2011 - 01/2004
4	Arthritis (Polyarthritis) 11/2009 - 11/2002
3	Peptic Esophagitis (Reflux Esophagitis) 01/2010 - 09/2003
3	Ulcerative Colitis 09/2007 - 09/2004
3	Pancreatitis 08/2006 - 03/2004
2	Diffuse Idiopathic Skeletal Hyperostosis 08/2022 - 12/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2020
2	Rheumatoid Arthritis 07/2018 - 09/2009
2	Pain (Aches) 03/2018 - 09/2007
2	Contact Dermatitis (Eczema, Contact) 01/2018 - 08/2017
2	Dermatitis 01/2018 - 08/2017
2	Wounds and Injuries (Trauma) 09/2017 - 08/2009
2	Hypersensitivity (Allergy) 11/2016 - 09/2007
2	Esophagitis 12/2014 - 01/2005
2	Edema (Dropsy) 01/2011 - 03/2004
1	Lordosis 08/2022
1	Ileitis 12/2021
1	Rotator Cuff Tear Arthropathy 01/2021
1	Back Pain (Backache) 12/2020
1	Colitis-Associated Neoplasms 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Disease Progression 07/2018
1	Ileus 01/2018

Drug/Important Bio-Agent (IBA)

9	Peroxidase (Myeloperoxidase)IBA 12/2021 - 09/2004
8	Dextrans (Dextran)FDA Link 01/2020 - 01/2016
7	Dextran SulfateIBA 06/2019 - 01/2004
6	Indomethacin (Indometacin)FDA LinkGeneric 12/2021 - 01/2006
6	SodiumIBA 01/2020 - 01/2016
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 05/2002
5	CytokinesIBA 12/2021 - 01/2015
5	AcidsIBA 01/2011 - 09/2003
4	Capsaicin (Zostrix)FDA Link 03/2018 - 09/2003
4	Fluorouracil (Carac)FDA LinkGeneric 10/2017 - 05/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 09/2007
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2011 - 01/2005
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2009 - 01/2005
4	rofecoxib (Vioxx)FDA Link 10/2007 - 11/2002
3	Pharmaceutical PreparationsIBA 12/2021 - 01/2004
3	CationsIBA 01/2020 - 01/2018
3	ProstaglandinsIBA 01/2011 - 01/2005
3	IsoenzymesIBA 09/2007 - 01/2005
3	Drinking WaterIBA 09/2007 - 01/2004
3	CeruletideIBA 08/2006 - 03/2004
2	Interleukin-6 (Interleukin 6)IBA 07/2018 - 01/2018
2	Substance PIBA 03/2018 - 01/2016
2	HaptensIBA 01/2018 - 08/2017
2	cadherin 5IBA 01/2018 - 01/2018
2	Evans Blue (Blue, Evans)FDA Link 01/2018 - 01/2018
2	ChemokinesIBA 01/2018 - 01/2017
2	Coloring Agents (Dyes)IBA 01/2018 - 01/2018
2	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 01/2018 - 01/2018
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 05/2012
2	Sulfonic AcidsIBA 01/2017 - 11/2016
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2016 - 01/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 01/2013
2	Diphosphonates (Bisphosphonates)IBA 01/2011 - 05/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 05/2002
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2011 - 05/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2009 - 01/2005
2	Urethane (Ethyl Carbamate)IBA 12/2008 - 05/2004
2	Ether (Diethyl Ether)IBA 10/2007 - 01/2005
2	SC 560IBA 10/2007 - 01/2006
2	Dinoprostone (PGE2)FDA Link 10/2007 - 01/2005
2	(S)-4-(1-(5-chloro-2-(4-fluorophenyoxy) benzamido)ethyl) benzoic acidIBA 10/2007 - 09/2007
2	Biomarkers (Surrogate Marker)IBA 12/2006 - 08/2005
2	Amylases FDA Link 08/2006 - 01/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2006 - 11/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2005 - 03/2004
2	Histamine (Histamine Dihydrochloride)FDA Link 10/2004 - 09/2003
2	lafutidineIBA 10/2004 - 09/2003
2	Thiobarbituric Acid Reactive SubstancesIBA 09/2004 - 01/2004
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	QuinazolinesIBA 12/2021
1	tranilastIBA 07/2021
1	Ion Channels (Ion Channel)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2020
1	bis(2- ((4- ((4'- (2- hydroxyethoxy)- 2'- methyl(1,1'- biphenyl)- 3- yl)methoxy)phenyl)methyl)- 3,5- dioxo- 1,2,4- oxadiazolidine)IBA 06/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2019
1	tocilizumab (atlizumab)FDA Link 07/2018
1	Calcitonin Gene-Related PeptideIBA 03/2018
1	AnkyrinsIBA 03/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018

Therapy/Procedure

4	Therapeutics 12/2021 - 03/2004
4	Anesthesia 12/2008 - 05/2004
2	Oral Administration 12/2021 - 07/2021
2	Drug Therapy (Chemotherapy) 10/2017 - 01/2015
2	Injections 09/2017 - 01/2005
1	Osteotomy 08/2022
1	Arthroplasty 01/2021
1	Activities of Daily Living (ADL) 12/2020
1	Intravenous Administration 01/2018